Emanuele Crupi, MD, discusses prospective data supporting GemFLP as a benchmark for treatment of advanced urachal and non-urachal urinary tract adenocarcinomas.
Emanuele Crupi, MD
Advertisement
Articles by Emanuele Crupi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Datopotamab deruxtecan enters phase 3 trial in high-risk muscle-invasive urothelial cancer
2
Nicole L. Miller, MD, FACS, on persistent LUTS after BPH treatment
3
AI system links surgical gestures with postoperative outcomes
4
Pearls & Perspectives: From Emergency Medicine to Sexual Medicine, With Jeff Myers, DO
5